ONCOMINE MYELOPROLIFERATIVE NEOPLASM MPN PANEL Test
Test Name: ONCOMINE MYELOPROLIFERATIVE NEOPLASM MPN PANEL Test
Components: ABL1, ASXL1, CBL, CALR, DNMT3A, EZH2, ETV6, FLT3, IDH1, IDH2, IKZF1, JAK2, KIT, MPL, NPM1, NRAS, NF1, RUNX1, SF3B1, SRSF2, SH2B3, STAG2, TET2, TP53, U2AF1, ZRSR2
FUSION GENE: ETV6, JAK2, KMT2A, RUNX1
Price: 8190.0 AED
Sample Condition: 3 mL (2 mL min.) whole Blood OR Bone Marrow in 1 Lavender top (EDTA) tube. Ship refrigerated. DO NOT FREEZE. Duly filled NGS Test Requisition Form is mandatory.
Report Delivery: Sample by 1st / 16th of every month; Report 15th / 30th of Same month
Method: NGS
Test type: Leukemia
Doctor: Hematologist, Oncologist
Test Department: MOLECULAR DIAGNOSTICS
Pre Test Information: Duly filled NGS Test Requisition Form is mandatory.
Test Details
The Oncomine Myeloproliferative Neoplasm (MPN) Panel Test is a diagnostic tool that is used to detect genetic mutations associated with MPN. This panel test analyzes 35 genes that are frequently mutated in MPN, including JAK2, CALR, and MPL.
MPN is a group of blood disorders that cause the bone marrow to produce too many blood cells. This can lead to a range of symptoms, including fatigue, weakness, and an enlarged spleen. MPN can also increase the risk of blood clots and other complications.
The Oncomine MPN Panel Test is performed using a small sample of blood or bone marrow. The test uses advanced sequencing technology to identify genetic mutations that may be causing the patient’s MPN. The results of the test can help guide treatment decisions and provide important information about the patient’s prognosis.
Overall, the Oncomine MPN Panel Test is a valuable tool for diagnosing and managing MPN, and it can help improve outcomes for patients with this challenging condition.
Test Name | ONCOMINE MYELOPROLIFERATIVE NEOPLASM MPN PANEL Test |
---|---|
Components | ABL1, ASXL1, CBL, CALR, DNMT3A, EZH2, ETV6, FLT3, IDH1, IDH2, IKZF1, JAK2, KIT, MPL, NPM1, NRAS, NF1, RUNX1, SF3B1, SRSF2, SH2B3, STAG2, TET2, TP53, U2AF1, ZRSR2FUSION GENE – ETV6, JAK2, KMT2A, RUNX1 |
Price | 8190.0 AED |
Sample Condition | 3 mL (2 mL min.) whole Blood OR Bone Marrow in 1 Lavender top (EDTA) tube. Ship refrigerated. DO NOT FREEZE. Duly filled NGS Test Requisition Formis mandatory. |
Report Delivery | Sample by 1st / 16th of every month; Report 15th / 30th of Same month |
Method | NGS |
Test type | Leukemia |
Doctor | Hematologist, Oncologist |
Test Department: | MOLECULAR DIAGNOSTICS |
Pre Test Information | Duly filled NGS Test Requisition Formis mandatory. |
Test Details | The Oncomine Myeloproliferative Neoplasm (MPN) Panel Test is a diagnostic tool that is used to detect genetic mutations associated with MPN. This panel test analyzes 35 genes that are frequently mutated in MPN, including JAK2, CALR, and MPL. MPN is a group of blood disorders that cause the bone marrow to produce too many blood cells. This can lead to a range of symptoms, including fatigue, weakness, and an enlarged spleen. MPN can also increase the risk of blood clots and other complications. The Oncomine MPN Panel Test is performed using a small sample of blood or bone marrow. The test uses advanced sequencing technology to identify genetic mutations that may be causing the patient’s MPN. The results of the test can help guide treatment decisions and provide important information about the patient’s prognosis. Overall, the Oncomine MPN Panel Test is a valuable tool for diagnosing and managing MPN, and it can help improve outcomes for patients with this challenging condition. |